Malaria vaccine shows over 50% efficacy in adults following controlled human malaria infection, supporting further trials in children.
Australian researchers have worked with global phamarceutical company MSD to co-develop a new antimalarial drug candidate designed to address the growing challenge of drug resistance and potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback